CAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis

Diabetologia

Volumn 56, Issue 2, 2013, Pages 412-422

  Min, A K ^a   Jeong, J Y ^a   Go, Y ^a   Choi, Y K ^a   Kim, Y D ^a   Lee, I K ^a   Park, K G ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

CREBH; Fenofibrate; Hepatic steatosis; Lipogenesis; SREBP 1c

Indexed keywords

FENOFIBRATE; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN H GENE; DOWN REGULATION; DRUG MECHANISM; FATTY LIVER; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C GENE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL LINE; CELL STRAIN HEPG2; DRUG EFFECT; HUMAN; LIVER; METABOLISM; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FATTY LIVER; FENOFIBRATE; HEP G2 CELLS; HUMANS; LIPOGENESIS; LIVER; MICE; RATS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

MLCS; MLOWN;

EID: 84878806915     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2771-2     Document Type: Article

References (46)

1. Marceau P, Biron S, Hould FS et al (1999) Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513-1517
2. Marchesini G, Brizi M, Morselli-Labate AM et al (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450-455
3. Horton JD (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30:1091-1095
4. Zammit VA, Waterman IJ, Topping D, McKay G (2001) Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131:2074-2077
5. Shimomura I, Bashmakov Y, Horton JD (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032
6. Cagen LM, Deng X, Wilcox HG, Park EA, Raghow R, Elam MB (2005) Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem J 385:207-216
7. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS (2002) Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 277:9520-9528
8. Lu M, Shyy JY (2006) Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am J Physiol Cell Physiol 290:C1477-C1486
9. Yamamoto T, Shimano H, Inoue N et al (2007) Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 282:11687-11695
10. Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferre P (1994) Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J 8:36-42
11. Rosenson RS (2008) Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome. Am Heart J 155:499.9-16
12. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088-2093
13. Bijland S, Pieterman EJ, Maas AC et al (2010) Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice. J Biol Chem 285:25168-25175
14. Kritchevsky D, Tepper SA, Story JA (1979) Influence of procetofen on lipid metabolism in normocholesteremic rats. Pharmacol Res Commun 11:635-641
15. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J (1997) Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 272:28210-28217
16. Schoonjans K, Watanabe M, Suzuki H et al (1995) Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 270:19269-19276
17. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925
18. Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109
19. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650
20. Staels B, Auwerx J (1992) Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and alpha-fetoprotein as models. Development 115:1035-1043
21. Chin KT, Zhou HJ, Wong CM et al (2005) The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma. Nucleic Acids Res 33:1859-1873
22. Omori Y, Imai J, Watanabe M et al (2001) CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. Nucleic Acids Res 29:2154-2162
23. Zhang K, Shen X, Wu J et al (2006) Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124:587-599
24. Foretz M, Guichard C, Ferre P, Foufelle F (1999) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 96:12737-12742
25. Lee JH, Giannikopoulos P, Duncan SA et al (2011) The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat Med 17:812-815
26. Zhang C, Wang G, Zheng Z et al (2012) Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. Hepatology 55:1070-1082
27. Horton JD, Bashmakov Y, Shimomura I, Shimano H (1998) Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A 95:5987-5992
28. Chen G, Liang G, Ou J, Goldstein JL, Brown MS (2004) Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101:11245-11250
29. Park KG, Min AK, Koh EH et al (2008) Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 48:1477-1486
30. Lee MW, Chanda D, Yang J et al (2010) Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab 11:331-339
31. Oosterveer MH, Grefhorst A, van Dijk TH et al (2009) Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem 284:34036-34044
32. Fernandez-Alvarez A, Soledad Alvarez M, Cucarella C, Casado M (2010) Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs. J Biol Chem 285:11765-11774
33. Kammoun HL, Chabanon H, Hainault I et al (2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 119:1201-1215
34. Yellaturu CR, Deng X, Park EA, Raghow R, Elam MB (2009) Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex. J Biol Chem 284:31726-31734
35. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152
36. Kim YW, Kim YM, Yang YM et al (2010) Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic Biol Med 48:567-578
37. Deng X, Yellaturu C, Cagen L et al (2007) Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1). J Biol Chem 282:17517-17529
38. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW (1997) Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46:1768-1774
39. Yang J, Craddock L, Hong S, Liu ZM (2009) AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. J Cell Biochem 106:414-426
40. Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607-614
41. Keech A, Simes RJ, Barter P et al (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366:1849-1861
42. Nieuwdorp M, Stroes ES, Kastelein JJ (2007) Normalization of metabolic syndrome using fenofibrate, metformin or their combination. Diabetes Obes Metabol 9:869-878
43. Zambon A, Cusi K (2007) The role of fenofibrate in clinical practice. Diabetes Vasc Dis Res 4(Suppl 3):S15-S20
44. Danno H, Ishii KA, Nakagawa Y et al (2010) The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha. Biochem Biophys Res Commun 391:1222-1227
45. Han C, Wang J, Li L, Wang L, Zhang Z (2009) The role of LXR alpha in goose primary hepatocyte lipogenesis. Mol Cell Biochem 322:37-42
46. Pawar A, Botolin D, Mangelsdorf DJ, Jump DB (2003) The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J Biol Chem 278:40736-40743